Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ABCL AbCellera Biologics > Detailed Quotes

ABCL AbCellera Biologics

Watchlist
10.810
-0.160-1.46%
Close  02/07 16:00 ET
10.820
+0.010+0.09%
Post Mkt Price 02/07 16:32 ET
High
11.025
Open
10.940
Turnover
14.00M
Low
10.560
Pre Close
10.970
Volume
1.30M
Market Cap
3.09B
P/E(TTM)
13.68
52wk High
14.970
Shares
286.10M
P/E(Static)
22.52
52wk Low
5.420
Float Cap
2.25B
Bid/Ask %
0.00%
Historical High
71.910
Shs Float
208.09M
Volume Ratio
0.98
Historical Low
5.420
Dividend TTM
--
Div Yield TTM
--
P/B
2.47
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.63%
Amplitude
4.24%
Avg Price
10.736
Lot Size
1
Float Cap
2.25B
Bid/Ask %
0.00%
Historical High
71.910
Shs Float
208.09M
Volume Ratio
0.98
Historical Low
5.420
Dividend TTM
--
P/B
2.47
Dividend LFY
--
Turnover Ratio
0.63%
Amplitude
4.24%
Avg Price
10.736
Lot Size
1
Price Forecast

News

Comment

Company Overview More
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
CEO: Dr. Carl L.G. Hansen, PhD
Market: NASDAQ
Listing Date: 12/11/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist